These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19321587)

  • 1. Various doses of soy isoflavones do not modify mammographic density in postmenopausal women.
    Maskarinec G; Verheus M; Steinberg FM; Amato P; Cramer MK; Lewis RD; Murray MJ; Young RL; Wong WW
    J Nutr; 2009 May; 139(5):981-6. PubMed ID: 19321587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of soy isoflavones on mammographic density and breast parenchyma in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial.
    Delmanto A; Nahas-Neto J; Traiman P; Uemura G; Pessoa EC; Nahas EA
    Menopause; 2013 Oct; 20(10):1049-54. PubMed ID: 23481125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammographic densities in a one-year isoflavone intervention.
    Maskarinec G; Williams AE; Carlin L
    Eur J Cancer Prev; 2003 Apr; 12(2):165-9. PubMed ID: 12671541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women.
    Verheus M; van Gils CH; Kreijkamp-Kaspers S; Kok L; Peeters PH; Grobbee DE; van der Schouw YT
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2632-8. PubMed ID: 18843004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study.
    Brink E; Coxam V; Robins S; Wahala K; Cassidy A; Branca F;
    Am J Clin Nutr; 2008 Mar; 87(3):761-70. PubMed ID: 18326616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo.
    Freedman M; San Martin J; O'Gorman J; Eckert S; Lippman ME; Lo SC; Walls EL; Zeng J
    J Natl Cancer Inst; 2001 Jan; 93(1):51-6. PubMed ID: 11136842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial.
    Wong WW; Lewis RD; Steinberg FM; Murray MJ; Cramer MA; Amato P; Young RL; Barnes S; Ellis KJ; Shypailo RJ; Fraley JK; Konzelmann KL; Fischer JG; Smith EO
    Am J Clin Nutr; 2009 Nov; 90(5):1433-9. PubMed ID: 19759166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic studies of isoflavones & mammographic density.
    Maskarinec G; Verheus M; Tice JA
    Nutrients; 2010 Jan; 2(1):35-48. PubMed ID: 22253990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of bazedoxifene on mammographic breast density in postmenopausal women with osteoporosis.
    Harvey JA; Holm MK; Ranganath R; Guse PA; Trott EA; Helzner E
    Menopause; 2009; 16(6):1193-6. PubMed ID: 19503006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens.
    Harvey JA; Pinkerton JV; Baracat EC; Shi H; Chines AA; Mirkin S
    Menopause; 2013 Feb; 20(2):138-45. PubMed ID: 23271189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women.
    Cigler T; Tu D; Yaffe MJ; Findlay B; Verma S; Johnston D; Richardson H; Hu H; Qi S; Goss PE
    Breast Cancer Res Treat; 2010 Apr; 120(2):427-35. PubMed ID: 19967558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165].
    Atkinson C; Warren RM; Sala E; Dowsett M; Dunning AM; Healey CS; Runswick S; Day NE; Bingham SA
    Breast Cancer Res; 2004; 6(3):R170-9. PubMed ID: 15084240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.
    Alekel DL; Van Loan MD; Koehler KJ; Hanson LN; Stewart JW; Hanson KB; Kurzer MS; Peterson CT
    Am J Clin Nutr; 2010 Jan; 91(1):218-30. PubMed ID: 19906801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women.
    Steinberg FM; Murray MJ; Lewis RD; Cramer MA; Amato P; Young RL; Barnes S; Konzelmann KL; Fischer JG; Ellis KJ; Shypailo RJ; Fraley JK; Smith EO; Wong WW
    Am J Clin Nutr; 2011 Feb; 93(2):356-67. PubMed ID: 21177797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density.
    Wu AH; Spicer D; Garcia A; Tseng CC; Hovanessian-Larsen L; Sheth P; Martin SE; Hawes D; Russell C; MacDonald H; Tripathy D; Su MY; Ursin G; Pike MC
    Cancer Prev Res (Phila); 2015 Oct; 8(10):942-51. PubMed ID: 26276750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
    Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial.
    Chen YM; Ho SC; Lam SS; Ho SS; Woo JL
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4740-7. PubMed ID: 14557449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal japanese women: a four-week study.
    Uesugi T; Fukui Y; Yamori Y
    J Am Coll Nutr; 2002 Apr; 21(2):97-102. PubMed ID: 11999549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.